Search results
Results From The WOW.Com Content Network
Opened. 1993. The Vanderbilt-Ingram Cancer Center is an NCI-designated Comprehensive Cancer Center in Nashville, TN. It is part of the Vanderbilt University Medical Center . The Vanderbilt Cancer Center was established in 1993 and received its initial NCI designation in 1995. It was renamed the Vanderbilt-Ingram Cancer Center in 1999 after a ...
Website. www .vanderbilthealth .com. The Vanderbilt University Medical Center ( VUMC) is a medical provider with multiple hospitals in Nashville, Tennessee, as well as clinics and facilities throughout Middle Tennessee. VUMC is an independent non-profit organization, but maintains academic affiliations with Vanderbilt University.
Banner - University Medical Center Tucson ( BUMCT ), formerly University Medical Center and the University of Arizona Medical Center, is a private, non-profit, 649-bed acute-care teaching hospital located on the campus of the University of Arizona in Tucson, Arizona. [1] BUMCT is the clinical partner of the University of Arizona College of ...
Rathmell is an oncologist and kidney cancer expert who leads the Vanderbilt University Medical Center in Nashville, Tenn. As leader of the NCI, Rathmell… White House taps Vanderbilt oncologist ...
For premium support please call: 800-290-4726 more ways to reach us
Mayo Clinic. National Institutes of Health. Vanderbilt-Ingram Cancer Center. Harold L. Moses is the Ingram Professor of Cancer Research, Professor of Cancer Biology, Medicine and Pathology, and director emeritus at the Vanderbilt-Ingram Cancer Center. He was president of the American Association for Cancer Research in 1991.
Three designations are recognized: Comprehensive Cancer Centers, Clinical Cancer Centers, and Basic Laboratory Cancer Centers. As of 2023, there are 55 Comprehensive Cancer Centers, 10 Clinical Cancer Centers, and 7 Basic Laboratory Cancer Centers. Almost all are associated with a university. Receiving the NCI-designation places cancer centers ...
William Pao (born 1967) is an oncologist and Executive Vice President and Chief Development Officer of Pfizer. [1] He was previously the head of Pharma Research and Early Development (pRED) at Roche and a professor of medicine at the Vanderbilt University Medical Center. He is best known for his work in molecular oncology and cancer genomics.